# Supraspan memory performance is impaired in subjective cognitive impairment compared to cognitively unimpaired individuals

**Authors:** Ove Almkvist, Måns Gyllenhammar, Sofia Norberg, Mia Lu Roeseler, Eric Westman, Urban Ekman

PMC · DOI: 10.1038/s41598-025-07664-5 · 2025-07-02

## TL;DR

People with subjective cognitive impairment show worse memory performance under memory overload compared to those without cognitive issues.

## Contribution

This study identifies objective memory impairment in SCI through supraspan memory performance.

## Key findings

- SCI individuals showed significant supraspan memory impairment compared to cognitively unimpaired individuals.
- Supraspan memory performance differentiated SCI from MCI and CU groups.
- CSF biomarkers and brain abnormalities did not add predictive value beyond diagnosis for supraspan memory in SCI.

## Abstract

The objective cognitive status is incompletely known in Subjective Cognitive Impairment (SCI) and similar constructs. To characterize subspan and supraspan memory performance in groups with SCI, Mild Cognitive Impairment (MCI), and Cognitively Unimpaired individuals (CU) in relation to brain atrophy and CSF biomarkers. Performance on subspan (Digit Span Forward) and supraspan memory (trial 1 in the Rey Auditory Verbal Learning test) was investigated in patients diagnosed with SCI (n = 237) and MCI (n = 1038) from memory clinics in the Stockholm region and CU individuals from Stockholm university, Department of Psychology (n = 124). All participants had an extensive cognitive assessment. In addition, MCI and SCI patients had a comprehensive clinical examination, brain imaging scan (medial temporal lobe, cortical global atrophy, and white-matter-hyperintensities), and CSF biomarker analyses (Abeta, p-tau, and total-tau). Groups differed significantly in demographic characteristics, which were adjusted for in all analyses. The three groups differed significantly on supraspan, but not subspan, memory performance in line with the severity of cognitive impairment. The test-by-group interaction was also significant showing that SCI was characterized by selective supraspan impairment in conjunction with memory overload and in contrast to the previous conception of no objective impairment in SCI. CSF biomarkers and brain abnormality in MTA, GCA, and WMH did not provide additional predictive power over the diagnostic group on supraspan in SCI. Supraspan memory performance differed by diagnostic group in relation to the degree of cognitive impairment in memory clinic participants (CU > SCI > MCI) indicating objective memory impairment in SCI interpreted as due to supraspan overload.

The online version contains supplementary material available at 10.1038/s41598-025-07664-5.

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}
- **Diseases:** brain atrophy (MESH:C566985), Cognitive Impairment (MESH:D003072), memory overload (MESH:D019190), white (MESH:D000090122), atrophy (MESH:D001284), brain abnormality (MESH:D001927), MCI (MESH:D060825), memory impairment (MESH:D008569), matter-hyperintensities (MESH:D056784)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12215460/full.md

---
Source: https://tomesphere.com/paper/PMC12215460